Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. hVIVO Share Price
  4. hVIVO Share Regulatory News
  5. Open Orphan

Pin to quick pickshVIVO Regulatory News (HVO)

hVIVO Information

Share Price Information for hVIVO (HVO)

Share Price is delayed by 15 minutes
Get Live Data
8.85    0.45 (5.36%)
Bid:
8.70
Ask:
9.00
Spread: 0.30 (3.448%)
Market Cap: £60.92m
HVO Live PriceLast checked at - London Stock Exchange

Intraday hVIVO Share Chart

Open Orphan

15 Jan 2020 17:30

RNS Number : 9383Z
FTSE Russell
15 January 2020
 

 

 

 

 

Open Orphan (UK): Merger with Hvivo (UK)Changes in FTSE UK Index Series

15 January 2020

Subject to the completion of the merger between Open Orphan (UK, constituent) and Hvivo (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

20 January 2020

 

* The number of shares is based on the merger terms of 2.47 new Open Orphan shares for every Hvivo share held.

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSSFWFIIESSEIF
123456789
Date   Source Headline
26th Jul 20237:00 amRNSTrading update
25th Jul 20237:00 amRNSFlu B challenge model
28th Jun 20237:00 amRNShMPV human challenge model
14th Jun 20238:00 amRNSDirector dealings
23rd May 202312:36 pmRNSResult of AGM
28th Apr 20237:00 amRNSAnnual Report and Notice of AGM
26th Apr 20237:00 amRNSFDA Breakthrough and Fast Track for US biotech
25th Apr 20237:00 amRNSFinal results
19th Apr 20237:10 amRNSNotice of Results
6th Apr 20233:54 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSPositive results from flu human challenge study
29th Mar 20237:00 amRNSPresentation at World Vaccine Congress
23rd Mar 20237:00 amRNSExercise of Options
16th Mar 20237:00 amRNSOmicron human challenge model update
6th Feb 20239:05 amRNSSecond Price Monitoring Extn
6th Feb 20239:00 amRNSPrice Monitoring Extension
6th Feb 20237:05 amRNSLong Term Incentive Plan / PDMR Notification
6th Feb 20237:00 amRNS£6.8m RSV human challenge contract signed
25th Jan 20239:06 amRNSSecond Price Monitoring Extn
25th Jan 20239:00 amRNSPrice Monitoring Extension
25th Jan 20237:00 amRNSTrading update
17th Jan 20237:00 amRNSEUR3.2m Venn contract with global pharma client
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
4th Jan 20237:00 amRNS£5.2m RSV contract and Notice of Trading update
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
3rd Jan 20232:00 pmRNSPrice Monitoring Extension
3rd Jan 202311:05 amRNSSecond Price Monitoring Extn
3rd Jan 202311:00 amRNSPrice Monitoring Extension
19th Dec 20227:00 amRNSImutex Phase I data published
17th Nov 20222:05 pmRNSSecond Price Monitoring Extn
17th Nov 20222:00 pmRNSPrice Monitoring Extension
14th Nov 202211:15 amEQShVIVO hails growing contract values after winning £13.6mln RSV challenge trial deal
11th Nov 20227:00 amRNSExercise of Options
10th Nov 202211:00 amRNSPrice Monitoring Extension
10th Nov 20228:22 amRNS£13.6m RSV antiviral contract
4th Nov 20227:25 amRNSHolding(s) in Company
17th Jan 20208:01 amRNSRule 2.9 Announcement
17th Jan 20207:00 amRNSOffer Wholly Unconditional
15th Jan 20205:30 pmRNSOpen Orphan
15th Jan 20208:01 amRNSRule 2.9 Announcement
14th Jan 20207:00 amRNSSecond Closing of the Offer
13th Jan 20204:31 pmRNSExercise of Share Options
13th Jan 20201:39 pmRNSExercise of Share Options
13th Jan 20208:01 amRNSRule 2.9 Announcement
9th Jan 20201:29 pmRNSExercise of Share Options
8th Jan 20207:01 amRNSDirector's Dealings
8th Jan 20207:00 amRNSExercise of Share Options
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
STCK
STCK.L
LSE
0.00%
GLE
MJGleeson
LSE
1.43%
SGLD
Inv Phys Gold
LSE
-2.78%
PHNX
Phoenix Group Holdings
LSE
0.00%
SAIN
Scot.amer.inv.
LSE
-0.36%
Trending
AVCT
Avacta Group
LSE
2.14%
PPP
Pennpetro Energy
LSE
0.00%
ITM
Itm Power
LSE
-10.85%
ALRT
Defence Holdings
LSE
19.05%
GST
GSTechnologies
LSE
8.11%